Over the past 3 years, this company has released accuracy percentages with sensitivity scores relating to there breast, ovarian and lung cancer tests. Figures ranging from 80-95 percent. Are these figures good enough for these tests to go commercial and if yes, what is the hold up?
BARD1 2020, page-56
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
0.005(1.04%) |
Mkt cap ! $53.53M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 49.0¢ | 48.0¢ | $51.72K | 106.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 39633 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 7815 | 1 |
View Market Depth
| Last trade - 12.49pm 17/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |